- Abstract:
-
Chronic glucocorticoid therapy causes rapid bone loss and clinical osteoporosis. We found that although the glucocorticoid, dexamethasone, stimulated osteoblast maturation, it also inhibited proliferation of a preosteoblastic cell line, MBA-15.4. The dexamethasone-induced decline in preosteoblast proliferation correlated with a 30-40% reduction in protein kinase C/TPA-stimulated mitogen-activated protein kinase (MAPK) activity. These steroid effects only became evident after 6-24 h treatment,...
Expand abstract - Publication status:
- Published
- Journal:
- Endocrinology
- Volume:
- 139
- Issue:
- 5
- Pages:
- 2423-2431
- Publication date:
- 1998-05-05
- DOI:
- EISSN:
-
1945-7170
- ISSN:
-
0013-7227
- URN:
-
uuid:1edd8425-178c-4e6b-96c8-57b096777a95
- Source identifiers:
-
107548
- Local pid:
- pubs:107548
- Language:
- English
- Keywords:
- Copyright date:
- 1998
Journal article
Inhibition of mitogen-activated protein kinase activity and proliferation of an early osteoblast cell line (MBA 15.4) by dexamethasone: role of protein phosphatases.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record